Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Roche Fined In Romania For Delaying Biosimilar Entry
Market Entry Delays Pushed Up Costs To National Insurer
Jan 27 2020
•
By
Ian Schofield
The Competition Council said Roche created barriers to market entry • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin